FEN1-mediated HR replaces NHEJ in enabling the progression of stressed replication forks in DNA-PKcs-deficient cancers and is related to the malignancy of tumors and resistance to clinical treatment (Fig. 7k). The gene discussed is FEN1; the disease is cancer.